Novanta Inc (NOVT) KPIs and segments
Close on Nov 17, 2026Market cap $4.36BP/E 73.9Yield –
KPIs & segments
Operating metrics and segments that drive Novanta's business
Novanta's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Automation Enabling Technologies($M)2 | 136 | 131 | 131 | 125 | 122 | 123 | 128 | 129 | 117 | 117 | |||
Robotics and Automation($M) | 80.1 | 80.0 | |||||||||||
Precision Manufacturing($M) | 45.2 | 48.7 | |||||||||||
Medical Solutions($M)2 | 130 | 126 | 128 | 123 | 119 | 110 | 110 | 116 | 119 | 114 | 138 | 83.4 | |
Advanced Surgery($M) | 61.7 | 52.6 | |||||||||||
Precision Medicine($M) | 60.8 | 63.1 | |||||||||||
Earlier reporting (last reported 2024)2 | |||||||||||||
United States($M) | 131 | 122 | 137 | 130 | 128 | 124 | 122 | 124 | 123 | 117 | 96.4 | 110 | |
Rest of Europe($M) | 38.1 | 42.2 | 34.1 | 36.7 | 34.8 | 31.8 | 34.8 | 30.6 | 32.5 | 31.0 | 38.9 | 34.3 | |
Germany($M) | 33.3 | 36.3 | 31.8 | 27.1 | 27.3 | 28.5 | 24.6 | 33.6 | 31.9 | 33.2 | 28.0 | 33.3 | |
Rest of Asia-Pacific($M) | 28.5 | 27.4 | 24.6 | 24.4 | 24.7 | 23.4 | 27.3 | 27.1 | 25.3 | 27.3 | 25.8 | 24.1 | |
China($M) | 25.5 | 23.5 | 25.7 | 24.3 | 21.8 | 21.4 | 23.9 | 24.6 | 19.0 | 17.1 | 19.1 | 15.7 | |
Other Countries($M) | 9.06 | 6.22 | 5.34 | 4.93 | 4.38 | 4.65 | 5.20 | 4.16 | 3.68 | 5.36 | 3.43 | 3.78 | |
Automation Enabling Technologies($M) | 36.6 | 31.1 | 28.8 | 27.4 | 26.9 | 31.5 | 30.9 | 30.1 | 21.5 | 23.9 | |||
Medical Solutions($M) | 13.6 | 16.7 | 14.6 | 15.9 | 6.63 | 14.0 | 7.04 | 16.3 | 18.1 | 16.0 | |||
Automation Enabling Technologies($M) | 71.6 | 62.8 | 62.7 | 59.2 | 58.2 | 59.4 | 63.9 | 60.6 | 55.0 | 55.5 | |||
Medical Solutions($M) | 50.3 | 52.2 | 51.5 | 52.7 | 49.5 | 46.0 | 45.0 | 49.4 | 49.3 | 46.2 | 70.6 | 34.0 | |
Earlier reporting (last reported 2024)2 | |||||||||||||
Automation Enabling Technologies($M) | 36.6 | 31.1 | 28.8 | 27.4 | 26.9 | 31.5 | 30.9 | 30.1 | 21.5 | 23.9 | |||
Medical Solutions($M) | 13.6 | 16.7 | 14.6 | 15.9 | 6.63 | 14.0 | 7.04 | 16.3 | 18.1 | 16.0 | |||
Earlier reporting (last reported 2024)3 | |||||||||||||
25 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-05.
See a number that looks wrong?